Merck & Co., Inc. Accumulated OCI 2008-2026 | MRK
Beta
What is accumulated oci?
Accumulated other comprehensive income (OCI) includes unrealized gains and losses from foreign currency translation, available-for-sale securities, and pension adjustments.
What is Merck & Co., Inc.'s current accumulated oci?
Merck & Co., Inc. (MRK) annual accumulated oci for 2025 was $-4.29B, a 13.31% increase from 2024. Merck & Co., Inc. accumulated oci for the quarter ending March 31, 2026 was $-4.06B.
What was Merck & Co., Inc.'s accumulated oci in 2024?
Merck & Co., Inc. annual accumulated oci for 2024 was $-4.95B, a 4.19% increase from 2023.
What was Merck & Co., Inc.'s accumulated oci in 2023?
Merck & Co., Inc. annual accumulated oci for 2023 was $-5.16B, a 8.24% decline from 2022.
Accumulated OCI History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-6.63B
→
FY2025
$-4.29B
080910111213141516171819202122232425
5 years selected
Accumulated OCI History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-4.29B | +13.3% | 10-K |
| FY2024 | $-4.95B | +4.2% | 10-K |
| FY2023 | $-5.16B | -8.2% | 10-K |
| FY2022 | $-4.77B | -7.7% | 10-K |
| FY2021 | $-4.43B | +33.2% | 10-K |
| FY2020 | $-6.63B | -7.1% | 10-K |
| FY2019 | $-6.19B | -11.7% | 10-K |
| FY2018 | $-5.54B | -12.9% | 10-K |
| FY2017 | $-4.91B | +6.0% | 10-K |
| FY2016 | $-5.23B | -26.0% | 10-K |
| FY2015 | $-4.15B | +4.0% | 10-K |
| FY2014 | $-4.32B | -96.8% | 10-K |
| FY2013 | $-2.20B | +53.1% | 10-K |
| FY2012 | $-4.68B | -49.5% | 10-K |
| FY2011 | $-3.13B | +2.6% | 10-K |
| FY2010 | $-3.22B | -16.2% | 10-K |
| FY2009 | $-2.77B | -8.3% | 10-K |
| FY2008 | $-2.55B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →